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Abstract
Author Manuscript

Background—BisGMA-based dental composites may release bisphenol A (BPA). Our purpose
was to assess changes in urinary BPA concentrations over 6-months follow-up in children and
adolescents receiving bisGMA-based restorations.
Methods—We collected urine and interviewed parents/guardians for BPA-related exposure
information before and approximately one-day, 14-days, and 6-months post-treatment among 91
participants aged 3–17 years needing composite restorations. We used multivariable linear
regression models to test associations between number of surface-restorations placed and changes
in urinary BPA concentrations.
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Results—Participants had on average 1.4 (sd=1.0) surfaces filled with composite at the first
treatment visit and a cumulative 2.3 (sd=1.6) surfaces filled during the study. Mean change in BPA
between pretreatment and next-day was 1.71 ng/mL (sd=9.94) overall and 0.87 (sd=5.98) after
excluding one participant with 8 surfaces filled at the visit. Overall, a greater number of composite
surface-restorations placed was associated with higher BPA in the next-day sample (posteriorocclusal eβ=1.47, 95% CI 1.18–1.83; P<0.001), but this was attenuated after restricting to the 88
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participants with ≤4 fillings (eβ=1.19, 95% CI 0.86, 1.64), and no association was observed using
14-day (eβ=0.94, 95% CI 0.75–1.18) or 6- month (eβ=0.88, 95% CI 0.74–1.04) samples.
Conclusions—Placement of bisGMA-based restorations in children and adolescents may
produce transient increases in urinary BPA concentration, which are no longer detectable
approximately 14-days or 6-months post-treatment in urine samples. When few restorations are
placed, increases in urinary BPA concentrations may not be detectable owing to high interindividual variation in BPA exposure.
Practical Implications—These results suggest that leaching of BPA from newly placed
composites ceases being detectable in urine within 2 weeks of restoration placement. The potential
human health impact of such short-term exposure remains uncertain.
Keywords
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Dental restoration; Dental care for children; Composites; Pediatric dentistry; Polymers; Bisphenol
A

INTRODUCTION

Author Manuscript

Bisphenol A (BPA) is a chemical used in the manufacturing of polycarbonate plastics and
epoxy resins that are used by nearly every industry, including dentistry. Concern over human
BPA exposure exists because BPA is an endocrine disrupting chemical, and animal studies
show that BPA has reproductive, developmental, and systemic toxic effects even at low
doses (e.g., <50 mg/kg/day).1–3 A causal role for BPA in human health problems remains to
be determined, and most studies to date have been cross-sectional.4,5 However, evidence
from prospective human studies suggests that prenatal or postnatal exposure to BPA is
associated with reproductive health measures (e.g. ovarian toxicity in women,6 delayed
puberty in boys7), and immune function8,9 and neurodevelopment in children.4
The possibility of adverse effects of BPA exposure in humans has driven research efforts to
identify BPA exposure sources, improve BPA exposure characterization in humans, and
produce BPA-free substitute products.10,11 The predominant exposure route in the general
population appears to be through foods and beverages manufactured and stored using BPAcontaining materials.12–17 However, such products account for only ~20% of the BPA
produced worldwide each year,11 and human biomonitoring studies suggest that non-dietary
exposure sources also exist.18,19

Author Manuscript

In dentistry, BPA is used to synthesize matrix monomers, such as bisphenol A glycidyl
dimethacrylate (bisGMA), that are commonly used in composite restorative and sealant
materials.20 The BPA structure has benefits of bulk, rigidity and strength.21 An unfavorable
feature of such composite materials is incomplete polymerization, which results in
shrinkage, marginal leakage, and degradation over time.21,22 Numerous studies have shown
that composite materials release various chemicals, including BPA, while in the oral
environment.23–25 The largest human biomonitoring study of this issue to date included 172
adults followed for a maximum of 30 h after receiving composite restorations. The study
reported increases in BPA and other related compounds in saliva within 1 h after restoration
placement, and an increased concentration of BPA in urine 9–30 h after placement.26
J Am Dent Assoc. Author manuscript; available in PMC 2017 August 01.
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However, the time window of chemical release from composite restorations may extend past
this initial placement period, throughout the life of the restoration, as the composite degrades
over time.24 In vitro studies indicate that storage time, as well as mechanical stress such as
chewing, and acidic food/beverage, are associated with release of chemical components of
composite.24,27,28 The extent to which BPA continues to be released over the long-term
remains unexamined in human biomonitoring studies. Even if very low dose (<no-observedadverse-effect-level) as suggested by in vitro studies,22 the possible chronic exposure may
have an impact on health outcomes, as low levels of endocrine disrupting chemicals are
sufficient for adverse effects in animal studies.2,29

Author Manuscript

The possibility of adverse health effects of composites was suggested in the New England
Children’s Amalgam Trial (NECAT), a 5-year clinical trial designed to test the safety of
dental amalgam for restorations: Children who were randomly assigned treatment with
composite had worse psychosocial health outcomes after 4–5 years compared to children
randomized to amalgam.30 Further analysis showed that greater treatment level of composite
restorations containing bisGMA was associated with increased behavioral problems, certain
neuropsychological measures, and, possibly, certain immune function markers.31–33
However, randomization to composite was not associated with altered physical
development,34 and there was no association between preventive sealants or other flowable
composite materials and psychosocial or neuropsychological health.35 While the dental
materials used in the trial have been shown to release BPA, bisGMA and related
materials,36–39 the trial did not measure changes in children’s urinary concentrations of BPA
or other compounds that may leach from composite. Thus, it remains uncertain the extent to
which composite restorations lead to BPA exposure in children.

Author Manuscript

The aim of this study was to examine changes in urinary BPA concentrations in children and
adolescents before and after placement of dental composite restorations, up to 6 months
post-treatment.

METHODS

Author Manuscript

The Composites and Urinary Bisphenol-a Study (CUBS) was a clinical study designed to
examine changes in urinary BPA concentration in pediatric dental patients after placement of
dental composite restorations over approximately 6 months follow-up. Figure 1 outlines the
enrollment eligibility criteria and data collection visits. Study participants were recruited
from 8 participating clinical sites in the greater Boston area: two academic hospital settings
(Tufts University School of Dental Medicine; Franciscan Hospital for Children), three
community health centers (Cambridge Health Alliance; Lynn Community Health Center;
Edward M. Kennedy Community Health Center), two private practices, and one oral health
research institute (The Forsyth Institute). The study was approved by a central institutional
review board (IRB) and each participating institutional IRB, including the IRB of the
independent research organization, New England Research Institutes, Inc. The analysis of
blinded specimens by the Centers for Disease Control and Prevention (CDC) laboratory was
determined not to constitute engagement in human subjects research. Written informed
consent was obtained from the parent or legal guardian of participants, and signed assent
was obtained from participants of appropriate age. Recruitment occurred February 2012
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through December 2013, and follow-up visits were completed in June 2014. A total of 113
patients were enrolled, of which 91 had at least one pre-treatment and one post-treatment
urine sample and were therefore included in statistical analyses.
Urine Sample Data Collection and Laboratory Methods

Author Manuscript

After enrollment, each parent/guardian completed a baseline interview with a data collector,
who then provided a polypropylene urine cup and instructions on collecting a first morning
urine sample. The instructions stated that parents should try to avoid having the participant
eat canned foods or drinks the day before collecting urine and provided step-by-step
directions for collecting, handling, and refrigerating urine samples if the first morning void
occurred prior to the arrival of the data collector. Two data collectors scheduled and
conducted all urine sample collection visits, generally at the participant’s home. Data
collectors obtained urine samples at two pretreatment visits and at three post-treatment
visits, scheduled to occur next morning, 14 days and 6 months approximately after
restoration placement (Figure 1). Of the two pretreatment samples, one was collected on the
morning of the restoration placement, and the other was collected in the morning one to
seven days prior to the treatment to ensure availability of at least one pretreatment sample
and to allow analysis of the within-person variability of BPA pretreatment. For participants
who needed more than one treatment visit to have all composite restorations placed, we
requested additional urine sample collections the next morning and approximately 14 days
after each additional treatment visit, with up to 7 post-treatment urine samples collected per
participant.

Author Manuscript

Data collectors transported each urine sample in a cooler to the processing area, where they
brought the sample to room temperature, aliquotted it into Nalgene® cryovials using a
sterile polypropylene pipette, and measured specific gravity using a calibrated refractometer
(Atago 4410 PAL-10S). Samples were then stored at −86 °C unPl shipment to the CDC
(Atlanta, GA). Staff members at the CDC performed laboratory assays to quantify the
concentration of total (free plus conjugated) species of urinary BPA using a modification of
the automated online solid-phase extraction-high performance liquid chromatographyisotope-dilution tandem mass spectrometry approach previously described.40 The limit of
detection (LOD) was 0.1 ng/mL.

Author Manuscript

At each urine collection visit, the data collector conducted a brief interview, which included
a 24 h food recall with probes for canned foods and use of plastic containers to gather
information on recent possible BPA exposure sources. The final urine sample collection
visit, which occurred approximately 6 months after the last treatment visit, marked the end
of active study participation.
Dental Materials and Data Collection
We aimed to standardize the dental materials and restoration placement procedures for study
participants across clinical sites. To be consistent with NECAT, the standard treatment
materials were Z100 restorative (3M ESPE, St. Paul, MN) with Optibond bonding agent
(Kerr, Orange, CA). Both materials contain bisGMA among other compounds. Similar to
many other bisGMA-containing composite restoratives, the composite restorative has been
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previously shown to release BPA and bisGMA.24,36–39 If patients needed sealants placed
while enrolled in the study, the standard sealant was Embrace (Pulpdent, Watertown, MA),
which contains no bisGMA or related compounds. All treatments and materials were used
according to manufacturers’ indications. For each dental visit that occurred between the first
study-related composite restoration until the patient’s final 6-month urine sample collection,
we collected data on the type of treatments received, tooth surfaces treated, rubber dam
usage, and manufacturers/brands of materials used. Because participants may have had
composites and sealants already in place prior to the first study-related treatment, the dentist
recorded the number of existing restored or sealed surfaces and material types present at
baseline.
Statistical Analysis

Author Manuscript

We calculated descriptive statistics for BPA concentrations at each visit. BPA concentrations
were log-normally distributed, therefore, we loge transformed concentrations prior to further
analysis. One sample had a BPA concentration below LOD; for this sample, we used LOD/
√2.41 We corrected BPA concentrations (ng/mL) for specific gravity to account for variations
in urine dilution.42 The primary dependent variable was change from baseline in logtransformed BPA concentration corrected for specific-gravity. For patients who provided two
pre-treatment urine samples, we used the geometric mean of the two samples, each corrected
for specific gravity, to obtain the baseline BPA concentration.43 We calculated the intraclass
correlation coefficient (ICC) to examine the temporal reproducibility of the two measures,
by dividing the estimate of between subject variance by the estimated total variance. For
patients who provided just one pre-treatment sample, the BPA concentration corrected for
specific gravity was used as the baseline BPA concentration.

Author Manuscript
Author Manuscript

The analysis included 91 participants who provided at least one pretreatment urine sample,
had at least one composite restoration newly placed, and provided at least one post-treatment
urine sample. Preliminary analyses included descriptive statistics on the change in urinary
BPA concentration from pretreatment to each post-treatment visit. In the main analyses, the
primary independent variable was the total number of surfaces restored with composite
while on-study. A secondary measure was the number of posterior occlusal surfaces restored
on-study. We used multivariable linear regression models to estimate the association
between composite treatment levels and change in BPA concentration from baseline to each
follow-up time point (next-day, 14-day, and 6-months post-treatment) separately. We
assessed several sociodemographic, dietary and other factors as potential predictors of BPA
concentration based on the published literature.13,14,44–46 Potential predictors of BPA
exposure considered as covariates in the models included: age, race/ethnicity, sex, body
mass index, parent/guardian education, household income, presence of orthodontic dental
materials, presence of dental sealants or composites at baseline, urine collection time,
location of urine sample storage prior to processing, and consumption of canned food, foods
microwaved in plastic, or foods and beverages in plastic containers within 24h of the urine
sample. Participants missing data on a potential confounder were included using an indicator
category for missing in that variable. We ran regression models for change in BPA with each
potential covariate; variables for which P<0.2 were entered into a single multivariable
model, which we then reduced to retain only variables for which P remained <0.2. The final
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models adjusted for baseline BPA concentration and household income as fixed variables,
and canned food consumption in the day prior to urine sample collection and the season of
urine sample collection as time-varying variables. The exponentiated beta coefficients
represent the percent change in urinary-BPA concentration from the pretreatment geometric
mean associated with each composite surface placed.

Author Manuscript

The sample size had 80% power to detect a difference of 0.3 standard deviations using
paired t-tests to compare urinary BPA values before and at various time points after the first
dental treatment. As few participants had additional treatment visits and provided additional
next-day or 14-day urine samples, analyses of pre/post changes in next day or 14 days after
additional treatments were exploratory. For example, 26 participants in the analysis provided
80% power to detect a difference of 0.6 standard deviations. In the regression models,
statistical significance was tested at level 0.05. All analyses were conducted using SAS v9.3
(Cary, NC).

RESULTS
Figure 1 provides a flow chart of the number of patients enrolled and urine sample
collections pre-treatment and during follow-up. Approximately half (N=49/91, 53.8%) of
participants had a single visit with composite placement. Of the participants who had
additional composite placement visits and provided additional urine samples, the median
time between the first and second treatment was 21 days, and between the first and third
treatment was 37 days. The final urine sample collection occurred at a median of 162 days
and mean 170 (sd=32) days, or approximately 5.7 months after treatment.

Author Manuscript

At baseline, study participants were on average 9.5 years old (sd=3.7) and represented a
diverse patient population in race/ethnicity, body size, and parental education level (Table 1).
Use of plastic containers for drinking was common, with over two-thirds reporting use on
some or most days. Few participants (n=14) reported canned food consumption in the day
prior to the pretreatment urine collection. Data on the number of restorations and sealants
present at baseline were available for 63 (69.2%) of participants, of which 39 (42.9%) had
composite restorations and 35 (38.5%) had sealants present.
Dental Treatment

Author Manuscript

At the first treatment visit, most participants (68.5% of the 89 with treatment 1) had only one
surface filled, while 23.6% had two surfaces, 6.7% had 3 or 4 surfaces, and one patient
(1.1%) had 8 surfaces filled, resulting in a mean 1.4 (sd 1.0) surfaces filled at this visit
(Table 2). Over the course of the study, including participants who required additional
treatment visits, the mean number of surfaces filled was 2.3 (sd=1.6, N=91). Overall, 43.9%
of participants had one surface filled with composite, 25.3% had two surfaces, 17.6% had
three surfaces, 8.8% had four surfaces, 2.2% (n=2) had six surfaces, and 2.2% (n=2) had
eight composite surface-restorations placed. Most filled surfaces were posterior occlusal
surfaces; both the mean and median number of posterior-occlusal surfaces filled during the
study were 2.0 (sd 1.4). Z100 restorative was used in 93.4% of participants (n=85/91). A
rubber dam was used for at least one filling in 51.6% of participants. Twenty participants
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had sealants placed during the course of the study, of which 16 (80%) used Embrace
material.
Urinary BPA Concentration
Pretreatment, the median BPA concentration unadjusted for specific gravity was 1.98 ng/mL,
with 75th percentile 3.80 ng/mL and 95th percentile 8.28 ng/mL. Corrected for specific
gravity, the geometric mean (sd) pretreatment BPA concentration was 3.32 ng/mL (sd=3.80,
min=0.43, max=23.41 ng/mL, N=91 participants). Among participants who had two pretreatment samples (N=84), there was a statistically significant correlation between the two
measures of BPA (P=0.02), with an intraclass correlation coefficient of 0.25. There was no
association between the number of pre-existing composite restorations and changes in BPA
concentration over follow-up (data not shown).
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Table 2 provides the mean change in BPA from baseline to each follow-up visit. Compared
to baseline, the mean BPA concentration was increased next-day post-treatment 1 (mean
change 1.71 ng/mL, sd=9.94, P=0.11, n=89 participants) and treatment 3 (mean change 1.97
ng/mL, sd=2.91, P=0.36, n=3 participants), but not treatment 2 (mean change −0.59 ng/mL,
sd=3.62, P=0.41, n=26 participants). The next-day group mean BPA concentration of 5.04
ng/mL [sd=10.11, min=0.56, max=81.8] corresponds to a 51.4% increase in the baseline
group mean of 3.33 ng/mL.
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In the multivariable linear regression model (Table 3), a greater number of surfaces filled
with composite at treatment 1 was associated with a greater change in urinary BPA
concentration the next day (P=0.002 for all surfaces, P<0.001 for posterior occlusal
surfaces), but not in the 14-day or 6-month samples. For each surface placed, a 37% increase
in geometric mean BPA concentration would be expected, controlling for other predictors of
BPA change.
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In sensitivity analysis, we explored the impact of participants with the highest number of
surfaces restored. The participant with 8 surfaces restored in a single visit had a considerably
higher BPA concentration the day after treatment (81.8 ng/mL) compared to other
participants (mean 4.17 ng/mL, range 0.56–35.1 ng/mL). Seven of the 8 surfaces were
poster-occlusal surfaces. The participant reported no canned food consumption within the
day prior to the urine sample collections and was not missing data on any covariates
included in the models. Excluding this participant, the mean change in BPA was 0.87 ng/mL
(sd=5.98), and the association between number of composite-restored surfaces and next-day
change was attenuated (multivariable-adjusted eβ=1.19, P=0.29 for posterior occlusal
surfaces, eβ=1.08, P=0.57 for all surfaces). Another participant accumulated 8 surface
fillings across three visits, at the last of which two surfaces were filled, and the next-day
BPA concentration was increased by 0.71 ng/mL from baseline. At the final visit
approximately 6 months later, both of these participants had BPA concentrations (1.52
ng/mL and 1.30 ng/mL) close to the median pretreatment value (2.12 ng/mL).
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DISCUSSION
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This study found that placement of a higher number of composites in children and
adolescents was associated with a greater increase in urinary BPA concentrations one day
after treatment, but there was no detectable increase at approximately 14 days or 6 months
after treatment, or when few restorations were placed. Adjusting for other predictors of
urinary-BPA concentration, each posterior-occlusal composite-surface restoration was
associated with a 47% increase next-day in the geometric mean baseline value, but the
association was attenuated to 19% when we excluded the only participant to have a
considerably higher number of 8 surfaces filled in a single visit. Given that an increase in
mean BPA concentration was no longer detectable approximately 14 days or 6 months later,
the findings of this study do not support the hypothesis that dental composites remain a
measurable BPA exposure source after a brief period post-placement in children and
adolescents.

Author Manuscript

CUBS is the first study designed to examine BPA exposure from dental composites over the
longer term. It is also the first longitudinal study including a sufficient sample size of
children and adolescents. Prior studies focused on the first 24–30 h after placement in adults.
We focused on children and adolescents for multiple reasons, including (a) findings from the
NECAT that children randomized to composites (vs. amalgam) and with higher numbers of
composite restorations performed worse on certain neuropsychosocial outcome measures
after 4–5 years follow-up;30–33 (b) data from numerous countries that children and
adolescents had higher urinary BPA concentrations compared to adults, with little
understanding as to the exposure sources or metabolic differences that may account for agerelated differences,46–48 and (c) knowledge that dental restorations are most frequently
placed at younger ages.49 In the US, more than 60% of 5–19 year olds have dental caries or
restorations present.49

Author Manuscript

The finding of a 51% increase in the overall mean BPA concentration the day after
restoration placement is consistent with results in adults from a prior study, which showed a
43% increase in the overall mean urinary BPA concentration 9 to 30 hours after composite
restoration placement.26 Also, despite the different ages, the pretreatment BPA
concentrations were similar in the two studies. Data from the US National Health and
Nutrition Examination Survey (NHANES) show that in recent years, BPA concentrations
have declined more among the population aged 6–19 y than among adults, bringing
reference values closer for the different age groups.44,48,50 Our observed distribution of
pretreatment BPA concentrations was within the range for reference values reported for 6–11
year olds and 12–18 year olds in the 2011–2012 NHANES.48 In NHANES, children with ≥7
restorations had 20% higher mean urinary BPA concentration compared to children with no
restorations (95% CI: −6, 53; P=0.13).51 However, NHANES did not have data on
restorative material type, hence combined amalgam, glass ionomer and other materials with
bisGMA-based composites, and other limitations in the cross-sectional design weakened the
ability to detect an association with bisGMA-based materials.51,52 In a meta-analysis of in
vitro studies of dental materials, it was estimated that one full crown molar restoration may
release an average 57.4 nmol of BPA per surface after 24 h, which implicated composites
alongside contaminated food (~43.8 nmol) as a relevant BPA source.24 Thus, the observation
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of a mean 43–51% increase in pretreatment BPA concentration within approximately one
day post-treatment supports the notion that placement of composite dental materials may
expose the patient, albeit transiently, to BPA.

Author Manuscript

Our lack of finding a longer-term association between composite placement and BPA
concentrations supports the American Dental Association (ADA) 2014 statement that most
residual BPA in bisGMA-based materials is probably locked inside the polymer matrix after
polymerization.22 The ADA’s in vitro analyses of various bisGMA-based composite
restoratives using artificial saliva highlighted the importance of polymerization in the first 48
h.22 Although composites are cured during placement, polymerization remains incomplete.
Thus, the mechanism of BPA exposure during and shortly after placement is thought to
involve leaching of non-polymerized components. In an in vitro study using dynamic
mechanical analysis to experiment with various mechanical and environmental stressors on
three different composite restoration material over 90 days, the researchers found that
storage in water or artificial saliva for 1 to 7 days caused post-curing reactions, but storage
for 30 or 90 days had no further effect for two of the three materials.53 Together, these
results support the notion that leaching of non-polymerized components of newly-placed
composite materials terminates after a few days to a few weeks from the start of
polymerization during treatment.28

Author Manuscript

The question remains whether degradation of composite restorations, typically occurring
over a course of many years after placement, results in chronic, low levels of BPA exposure.
The CUBS follow-up time of approximately 6 months post-treatment was too short to
include the typical life span of restorations including degradation, which may extend well
over 10–20 years for current materials.54 In addition, few participants had more than one
treatment visit during follow-up, and the sample sizes were not sufficient for hypothesis
testing after each additional treatment visit. As such, changes in BPA concentration next-day
or 14-days after treatment 2 or treatment 3 were analyzed as exploratory analysis, and results
were presented for completeness rather than to draw conclusions.

Author Manuscript

The consistency in dental materials used in CUBS and NECAT was intended to help explore
changes in urinary BPA as a possible source for health outcomes observed in NECAT.
However, the ability to generalize from CUBS participants to NECAT participants, or to
patients receiving multiple surface fillings in one visit, was limited by the low treatment
needs in CUBS participants. In NECAT, children had an average of 9.3 surfaces with caries
at the first dental examination, whereas the average was only 2.3 surfaces in CUBS.31 The
results of both studies point to the possibility of dose-response relationships, but the CUBS
data were insufficient to thoroughly examine high treatment levels, as few participants had
more than 3 surfaces filled. Given that the most striking increase in next-day urinary BPA
concentration was in a patient with 8 surfaces filled in a single visit, it is possible that for the
majority of patients who received just one or two surface fillings, changes in BPA
concentrations were not measurable in the context of high inter-individual variation. That is,
large variation in BPA may decrease the power to detect very small changes associated with
dental treatment. Furthermore, while only two CUBS participants had more than 7 surfaces
restored on-study (2.2%), 21.3% of the children in a published NHANES analysis51 had 7 or
more restorations (maximum=42). As such, the patient sample in CUBS was not suitable to
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examine associations with the high levels of composite treatment that may often occur in the
general population. It remains uncertain if children receiving more than three fillings in one
visit have a greater increase and/or extended release over time in BPA concentration.

Author Manuscript

High within-person variability in urinary BPA concentration and BPA’s short half-life (~6 h
through oral route)55 are problematic in long-term studies, as single spot samples may be
dramatically affected by acute exposures, such as food consumption.56 Given this
knowledge, we took numerous steps to in both our design and analysis to strengthen our
ability to detect an association with composite placement. First, we considered non-dental
BPA exposure sources. For example, we requested participants refrain from consuming
canned foods and collected detailed data on foods/beverages consumed and preparation
methods in the day prior to each urine collection. In the analysis, canned food consumption
and season of urine collection were indeed time-varying predictors of urinary BPA changes.
Second, we collected two pretreatment urine samples, which allowed us to evaluate baseline
variability. The ICC of 0.25 was consistent with results of other studies of urinary BPA
concentration in children57 or adults.58,59 A study of Australian children found that a single
sample provided moderately reliable assessment of BPA exposure in children, with 68% of
individuals correctly classified by a single sample, and 76% correctly classified by 2
samples.60 Third, we followed recommendations from prior studies to request standardized
timing (first morning) of collections, record the time of day and handling of samples, and
measure urine dilution using specific gravity.42,58
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In conclusion, placement of composite restorations in children and adolescents was
associated with transient increases in urinary BPA concentration, which were no longer
detectable at approximately 2 weeks or 6 months post-placement or after excluding study
participants receiving high number of fillings in a single visit. The magnitude of change in
BPA may depend on the number of surfaces restored, and additional research would be
needed to precisely estimate such changes among children with more than 3 surfaces filled
in one visit. It is unlikely that pre-existing composite restorations or sealants are measurable
BPA exposure sources, but further research would be necessary particularly for failed
restorations or degradation of restorations over their lifespan. Given that the human health
effects of BPA remain to be determined, this study was not designed to directly affect
clinical practice. Nonetheless, dentists should be aware of possible concerns regarding BPA
exposure and take steps to prevent exposure during and shortly after treatment, such as
improved methods for curing.61 Alternatives to bisGMA-based materials are increasing
available, in part owing to concerns over BPA.21 For comprehensive safety and benefit-risk
assessments, more information would be needed on human health effects of BPA and
alternatives, as the benefits of composite restorations are well-established.
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Patient Eligibility Criteria and Flow through Study Visits
*Additional visits were not required by the study protocol, but some participants had
additional treatment visits to complete their composite treatment needs. Such participants
were asked, but not required, to provide additional next-day and 14-day urine samples after
each additional treatment visit (scheduled to occur approximately 2–3 weeks apart). For
participants with multiple visits, the final urine sample collection was scheduled to occur
approximately 6 months after the final restoration treatment visit.
†Includes 40 par0cipants who received composite at the first treatment, and 2 par0cipants
who a2ended the first visit but did not receive composite restorations until the 2nd visit.
‡Includes 9 children who received composite at all 3 visits, and the 2 par0cipants who
received composite restorations only at visits 2 and 3.

Author Manuscript
J Am Dent Assoc. Author manuscript; available in PMC 2017 August 01.

Maserejian et al.

Page 16

Table 1

Author Manuscript

Baseline Characteristics of CUBS Participants in the Analysis (N=91)*
Age, years, mean (sd)

9.5 (± 3.7)

Sex
Male

47 (53.4%)

Female

41 (46.6%)

Race/Ethnicity
Hispanic

35 (38.5%)

White

24 (26.4%)

Black

16 (17.6%)

Other/missing

16 (17.6%)

Body mass index, kg/m2, mean (sd)

19.6 (± 6.0)

Author Manuscript

Education level of parent/guardian
No high school diploma

18 (20.7%)

High school graduate

30 (34.5%)

College graduate or above

39 (44.8%)

Household income
< $20,000

21 (23.1%)

$20,000-$50,000

21 (23.1%)

$50,000+

22 (24.2%)

Missing

27 (29.7%)

Frequency of drinking from plastic containers

Author Manuscript

Almost every day

37 (42.0%)

Some days

23 (26.1%)

Never

28 (31.8%)

Consumed canned food in the previous 24 h
No

77 (84.6%)

Yes

14 (15.4%)

Composite restorations present
Missing data

28 (30.8%)

No

24 (26.4%)

Yes

39 (42.9%)

Mean (SD)

3.4 (4.2)

Median (Q1, Q3)

2 (1, 4)

Sealants (preventive pit and fissure) present

Author Manuscript

Missing data

28 (30.8%)

No

28 (30.8%)

Yes

35 (38.5%)

Mean (SD)

3.8 (2.4)
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Median (Q1, Q3)

4 (2, 6)

Plastic space maintainers present

Author Manuscript

No

86 (95.6%)

Yes

4 (4.4%)

BPA concentration specific-gravity adjusted (ng/mL)
Mean (SD)
Median (min, max)

3.32 (3.80)
2.12 (0.43, 23.41)

*

Percentages are calculated excluding participants missing data from the denominator, except for race/ethnicity, household income, composite
restorations present, and sealants present. Missing data at baseline for other variables were as follows: sex n= 3; education level n=4, drinking from
plastic containers n=3, plastic space maintainers present, n=1. The total sample size (N=91) is comprised of 89 participants treated with composite
at the first visit and 2 participants who had no composite treatment at that visit but received composite at visits 2 and 3.
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81
26
15
3
5
77

14 days post-treatment visit 1

Next day post-treatment visit 2

14-day post-treatment visit 2

Next day post-treatment visit 3†

14-day post-treatment visit 3

Final visit (approximately 6 mo)

2 (1, 8)

5 (3, 8)

5 (3, 8)

3 (2, 6)

3 (2, 6)

1 (1, 8)

1 (1, 8)

Median (Min, Max)

2.3 (1.6)

5.0 (1.9)

5.3 (2.5)

2.9 (1.2)

3.1 (1.3)

1.4 (1.0)

1.4 (1.0)

Mean (sd)

2.12

1.53

1.10

1.79

2.10

2.13

1.97

Median

3.07 (3.01)

1.91 (1.38)

1.03 (0.53)

3.21 (2.36)

3.45 (3.35)

3.45 (3.97)

3.33 (3.84)

Mean (sd)

Baseline Urinary BPA (ng/mL)

−0.17

−0.02

0.71

−0.34

−0.50

−0.15

0.28

Median

0.29 (4.66)

−0.27 (1.28)

1.97 (2.91)

−0.28 (3.55)

−0.59 (3.62)

−0.50 (4.09)

1.71 (9.94)

Mean (sd)

Change in Urinary BPA (ng/mL)

9.4%

−14.1%

191.3%

−0.4%

−17.1%

−14.5%

51.4%

Percent Change in Group Mean

Of the 3 participants with a visit 3, the number of surfaces filled at visits 1, 2 and 3, respectively, were as follows: 1, 1, 1 (total 3 surfaces); 2, 2, 1 (total 5 surfaces); and 3, 3, 2 (total 8 surfaces).

†

Results in table included all participants. Excluding the participant with 8 surfaces restored at visit 1 and with high next-day BPA concentration of 81.8 ng/mL, results were: median baseline 1.90 ng/mL;
mean baseline 3.30 (sd 3.86) ng/mL; median change 0.25 ng/mL, mean change 0.87 (sd 5.98) ng/mL, percent change in group mean 26.4%.

*

89

N

Next day post-treatment visit 1*

Change from Baseline to:

No. Surfaces Restored Cumulatively

Number of Composite Restorations Placed and Change in Urinary BPA Concentrations between Baseline and Each Follow-up Visit
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81
77

14 days after composite placement

6 months after composite placement

0.93

0.93

1.37

eβ

0.81, 1.08

0.78, 1.16

1.13, 1.67

95% CI

0.35

0.64

0.002

P-value

77

81

89

N

0.88

0.94

1.47

eβ

0.74, 1.04

0.75, 1.18

1.18, 1.83

95% CI

0.13

0.60

<0.001

P-value

Posterior Occlusal Surfaces

Results in table included all participants. Excluding the participant with 8 surfaces restored at visit 1 and with high next-day BPA concentration of 81.8 ng/mL, results for next day were: all surfaces eβ =

1.08 (95% CI 0.81, 1.47), P=0.57; posterior-occlusal surfaces eβ =1.19 (95% CI 0.86, 1.64), P=0.29.

†

The regression models analyzed the outcome of log-transformed BPA corrected for specific gravity. Values presented as eβ are the back-transformed coefficients. Models adjusted for baseline BPA
concentration and household income as fixed covariates, and level of canned food consumption in the day prior to urine sample collection and season of urine sample collection as time-varying covariates.
The available sample sizes for BPA concentration measured after treatment visits 2 and 3 were insufficient for modeling analyses.

*

89

Next day after composite placement†

Change from Baseline to Visit:

N

All Surfaces

Type of Composite Surface Restored

Association between Number of Surfaces Restored with Composite and Change from Baseline in BPA from Regression Models*
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